Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steven eSimoens"'
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
This study presents industry perspectives on the challenges related to market access of innovative drugs in general and oncology drugs in specific. Fifteen interviews were conducted with representatives of pharmaceutical companies and industry associ
Externí odkaz:
https://doaj.org/article/5d381b81fa2f4fea93f1fb64cac1a2af
Publikováno v:
Frontiers in Pharmacology, Vol 6 (2015)
Background: Drug shortages are currently on the rise. In-depth investigation of the problem is necessary, however, a variety of definitions for ‘drug shortages’ are formulated in legislations, by different organisations, authorities and other ini
Externí odkaz:
https://doaj.org/article/5cd255443329490da4f9d58681c27acd
Autor:
James eMoon, Brian eGodman, Max ePetzold, Samantha eAlvarez-Madrazo, Kathleen eBennett, Iain eBishop, Anna eBucsics, Ulrik eHesse, Andrew eMartin, Steven eSimoens, Corinne eZara, Rickard E Malmstrom
Publikováno v:
Frontiers in Pharmacology, Vol 5 (2014)
Introduction: There is an urgent need for health authorities across Europe to fully realise potential savings from increased use of generics to sustain their healthcare systems. A variety of strategies were used across Europe following the availabili
Externí odkaz:
https://doaj.org/article/e7e750d15b714811ba798b4b87e29e8b
Autor:
Rickard eMalmstrom, Brian eGodman, Eduardo eDiogene, Christoph eBaumgaertel, Marion eBennie, Iain eBishop, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alessandra eFerrario, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Miguel eGomes, Iñaki eGutiérrez-Ibarluzea, Alan eHaycox, Krystyna eHviding, Harald eHerholz, Mikael eHoffmann, Saira eJan, Jan eJones, Roberta eJoppi, Marija eKalaba, Christina eKvalheim, Ott eLaius, Irene eLangner, Julie eLonsdale, Sven-Ake eLoov, Kamila eMalinowska, Laura eMcCullagh, Ken ePaterson, Vanda eMarkovic-Pekovic, Andrew eMartin, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Steven eSimoens, Faik Cankat Tulunay, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Michael eWilcock, Magda eWladysiuk, Menno van Woerkom, Corrine eZara, Lars L Gustafsson
Publikováno v:
Frontiers in Pharmacology, Vol 4 (2013)
Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are safety and/ or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with
Externí odkaz:
https://doaj.org/article/ddc4fb6f64674453bbdb1706aa447bdf
Publikováno v:
Frontiers in Pharmacology, Vol 2 (2011)
This Perspective describes (a) the current situation, (b) challenges and initiatives, (c) and formulates recommendations to valorize and create access to innovative medicines in the EU. We are currently still far away from optimal assessment of value
Externí odkaz:
https://doaj.org/article/e9c663b1e4654f7cae2add133fd1081f